Anabolic-androgenic steroid dependence: An emerging disorder

Addiction

Volumn 104, Issue 12, 2009, Pages 1966-1978

  Kanayama, Gen ^a,b   Brower, Kirk J ^c   Wood, Ruth I ^d   Hudson, James I ^a,b   Pope Jr , Harrison G ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anabolic steroids; Androgens; Men; Performance enhancing drugs; Substance abuse; Substance dependence; Testosterone

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

BODY BUILDING; CAUSAL ATTRIBUTION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DEPENDENCE; HUMAN; MORTALITY; NONHUMAN; OPIATE ADDICTION; PREVALENCE; REVIEW; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADULT; ANABOLIC AGENTS; ANIMALS; COCAINE-RELATED DISORDERS; CRICETINAE; DOPING IN SPORTS; HUMANS; MALE; MENTAL DISORDERS; MUSCLE, SKELETAL; OPIOID-RELATED DISORDERS; PREVALENCE;

EID: 70349638403     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02734.x     Document Type: Review

References (160)

1. Pope H. G., Brower K. J. Anabolic-androgenic steroid-related disorders. In : Sadock B., Sadock V., editors. Comprehensive Textbook of Psychiatry, 9th edn. Philadelphia, PA : Lippincott Williams & Wilkins 2009, p. 1419 1431.
2. Kouri E. M., Pope H. G. Jr., Katz D. L., Oliva P. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med 1995 5 : 223 228.
3. Wade N. Anabolic steroids: doctors denounce them, but athletes aren't listening. Science 1972 176 : 1399 1403.
4. Hildebrandt T., Schlundt D., Langenbucher J., Chung T. Presence of muscle dysmorphia symptomology among male weightlifters. Compr Psychiatry 2006 47 : 127 135.
5. Buckley W. E., Yesalis C. E. III., Friedl K. E., Anderson W. A., Streit A. L., Wright J. E. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988 260 : 3441 3445.
6. Kanayama G., Pope H. G. Jr., Hudson J. I. 'Body image' drugs: a growing psychosomatic problem. Psychother Psychosom 2001 70 : 61 5.
7. Parkinson A. B., Evans N. A. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 2006 38 : 644 651.
8. Kanayama G., Hudson J. I., Pope H. G. Demographic and psychiatric features of men with anabolic-androgenic steroid dependence: a comparative study. Drug Alcohol Depend 2009 102 : 130 137.
9. Kanayama G., Hudson J. I., Pope H. G. Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 2008 98 : 1 12.
10. Duchaine D. The Original Underground Steroid Handbook. Santa Monica, CA : OEM Publishing 1981.
11. Duchaine D. Underground Steroid Handbook. Santa Monica, CA : OEM Publishing 1983.
12. Duchaine D. Underground Steroid Handbook II. Los Angeles, CA : HLR Technical Books 1988.
13. Phillips W. Anabolic Reference Guide. Golden, CO : Mile High Publishing 1985.
14. Phillips W. Anabolic Reference Update. Golden, CO : Mile High Publishing 1991.
15. Leit R. A., Pope H. G. Jr., Gray J. J. Cultural expectations of muscularity in men: the evolution of Playgirl centerfolds. Int J Eat Disord 2001 29 : 90 3.
16. Pope H. G. Jr., Phillips K. A., Olivardia R. The Adonis Complex: The Secret Crisis of Male Body Obsession. New York : Simon & Schuster 2000.
17. Pope H. G. Jr., Gruber A. J., Choi P., Olivardia R., Phillips KA. Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. Psychosomatics 1997 38 : 548 557.
18. Pope H. G. Jr., Olivardia R., Borowiecki J. J. III., Cohane G. H. The growing commercial value of the male body: a longitudinal survey of advertising in women's magazines. Psychother Psychosom 2001 70 : 189 192.
19. Pope H. G. Jr., Olivardia R., Gruber A. J., Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord 1999 26 : 65 72.
20. Centers for Disease Control and Prevention (CDC); United States Department of Health and Human Services. Youth risk behavior surveillance - United States, 2007. MMWR 2008 57 (SS-4). Available at: http://www.cdc.gov/ HealthyYouth/yrbs/pdf/yrbss07-mmwr.pdf (accessed 8 August 2009).
21. Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future National Survey Results on Drug Use, 1975-2005. Volume II: College Students and Adults Ages 19-45. NIH Publication no. 06-5884. Bethesda, MD : National Institute on Drug Abuse 2006.
22. McCabe S. E., Brower K. J., West B. T., Nelson T. F., Wechsler H. Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys. Drug Alcohol Depend 2007 90 : 243 251.
23. Handelsman D. J., Gupta L. Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. Int J Androl 1997 20 : 159 164.
24. Melia P., Pipe A., Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med 1996 6 : 9 14.
25. Kokkevi A., Fotiou A., Chileva A., Nociar A., Miller P. Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst Use Misuse 2008 43 : 2053 2065.
26. Thiblin I., Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol 2005 19 : 27 44.
27. Nilsson S., Baigi A., Marklund B., Fridlund B. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur J Public Health 2001 11 : 195 197.
28. Pallesen S., Josendal O., Johnsen B. H., Larsen S., Molde H. Anabolic steroid use in high school students. Subst Use Misuse 2006 41 : 1705 1717.
29. Galduroz J. C., Noto A. R., Nappo S. A., Carlini E. A. Household survey on drug abuse in Brazil: study involving the 107 major cities of the country - 2001. Addict Behav 2005 30 : 545 556.
30. Rachon D., Pokrywka L., Suchecka-Rachon K. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed 2006 51 : 392 398.
31. Wanjek B., Rosendahl J., Strauss B., Gabriel H. H. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med 2007 28 : 346 353.
32. Pope H. G. Jr. Widespread anabolic steroid use in American girls and women: an illusion? Testimony before the United States House of Representatives Committee on Government Reform. Washington, DC, 15 June 2005.
33. Gruber A. J., Pope H. G. Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000 69 : 19 26.
34. Malarkey W. B., Strauss R. H., Leizman D. J., Liggett M., Demers L. M. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol 1991 165 : 1385 1390.
35. Kanayama G., Boynes M., Hudson J. I., Field A. E., Pope H. G. Jr. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend 2007 88 : 156 162.
36. Kanayama G., Pope H. G. Jr., Cohane G., Hudson J. I. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend 2003 71 : 77 86.
37. Pope H. G. Jr., Katz D. L. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994 51 : 375 382.
38. Summers J. Steroids 101. Aurora, CO : Anabolics.com 2003.
39. Reyes-Fuentes A., Veldhuis J. D. Neuroendocrine physiology of the normal male gonadal axis. Endocrinol Metab Clin North Am 1993 22 : 93 124.
40. Swerdloff R. S., Wang C., Hikim A. P. S. Hypothalamic-pituitary-gonadal axis in men. In : Pfaff D., Arnold A., Etgen A., Fahrbach S., Rubin R., editors. Hormones, Brain and Behavior, vol. 5. San Diego, CA : Elsevier 2002, p. 1 36.
41. Cohen J., Collins R., Darkes J., Gwartney D. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr 2007 4 : 12.
42. Collins R. Legal Muscle: Anabolics in America. East Meadow, NY : Legal Muscle Publishing 2002.
43. Brower K. J. Anabolic steroid abuse and dependence. Curr Psychiatry Rep 2002 4 : 377 387.
44. Basaria S., Wahlstrom J. T., Dobs A. S. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001 86 : 5108 5117.
45. Tennant F., Black D. L., Voy R. O. Anabolic steroid dependence with opioid-type features. N Engl J Med 1988 319 : 578.
46. Brower K. J., Blow F. C., Beresford T. P., Fuelling C. Anabolic-androgenic steroid dependence. J Clin Psychiatry 1989 50 : 31 3.
47. Hays L. R., Littleton S., Stillner V. Anabolic steroid dependence. Am J Psychiatry 1990 147 : 122.
48. Brower K. J., Eliopulos G. A., Blow F. C., Catlin D. H., Beresford T. P. Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry 1990 147 : 510 512.
49. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. Washington, DC : American Psychiatric Association 1987.
50. Brower K. J., Blow F. C., Young J. P., Hill E. M. Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict 1991 86 : 759 768.
51. Copeland J., Peters R., Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend 2000 60 : 91 6.
52. Midgley S. J., Heather N., Davies J. B. Dependence-producing potential of anabolic-androgenic steroids. Addict Res 1999 7 : 539 550.
53. Gridley D. W., Hanrahan S. J. Anabolic-androgenic steroid use among male gymnasium participants: knowledge and motives. Sports Health 1994 12 : 11 4.
54. Perry P. J., Lund B. C., Deninger M. J., Kutscher E. C., Schneider J. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization. Clin J Sport Med 2005 15 : 326 330.
55. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (DSM-IV). Washington, DC : American Psychiatric Association 1994.
56. Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York : New York State Psychiatric Institute 1989.
57. Malone D. A. Jr., Dimeff R. J., Lombardo J. A., Sample R. H. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med 1995 5 : 25 31.
58. Larance B., Degenhardt L., Copeland J., Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev 2008 27 : 679 686.
59. Pope H. G. Jr., Katz D. L. Psychiatric effects of exogenous anabolic-androgenic steroids. In : Wolkowitz O. M., Rothschild A. J., editors. Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Washington, DC : American Psychiatric Press 2003, p. 331 358.
60. Johnson M. D., Jay M. S., Shoup B., Rickert V. I. Anabolic steroid use by male adolescents. Pediatrics 1989 83 : 921 924.
61. Bahrke M. S., Yesalis C. E., Brower K. J. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child Adolesc Psychiatr Clin N Am 1998 7 : 821 838.
62. DuRant R. H., Rickert V. I., Ashworth C. S., Newman C., Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993 328 : 922 926.
63. Middleman A. B., Faulkner A. H., Woods E. R., Emans S. J., DuRant R. H. High-risk behaviors among high school students in Massachusetts who use anabolic steroids. Pediatrics 1995 96 : 268 272.
64. Scott D. M., Wagner J. C., Barlow T. W. Anabolic steroid use among adolescents in Nebraska schools. Am J Health Syst Pharm 1996 53 : 2068 2072.
65. Kashkin K. B., Kleber H. D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA 1989 262 : 3166 3170.
66. Arvary D., Pope H. G. Jr. Anabolic-androgenic steroids as a gateway to opioid dependence. N Engl J Med 2000 342 : 1532.
67. McBride A. J., Williamson K., Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use. Br J Sports Med 1996 30 : 69 70.
68. Wines J. D. Jr., Gruber A. J., Pope H. G. Jr., Lukas S. E. Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addict 1999 8 : 161 164.
69. Kanayama G., Cohane G. H., Weiss R. D., Pope H. G. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry 2003 64 : 156 160.
70. Thiblin I., Lindquist O., Rajs J. Cause and manner of death among users of anabolic-androgenic steroids. J Forensic Sci 2000 45 : 16 23.
71. Wood R. I. Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol 2008 29 : 490 506.
72. Alexander G. M., Packard M. G., Hines M. Testosterone has rewarding affective properties in male rats: implications for the biological basis of sexual motivation. Behav Neurosci 1994 108 : 424 428.
73. Arnedo M. T., Salvador A., Martinez-Sanchis S., Gonzalez-Bono E. Rewarding properties of testosterone in intact male mice: a pilot study. Pharmacol Biochem Behav 2000 65 : 327 332.
74. Wood R. I. Anabolic steroids: a fatal attraction? J Neuroendocrinol 2006 18 : 227 228.
75. Peters K. D., Wood R. I. Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience 2005 130 : 971 981.
76. Foltin R. W. The importance of drug self-administration studies in the analysis of abuse liability: an analysis of caffeine, nicotine, anabolic steroids, and designer drugs. Am J Addict 1992 1 : 139 149.
77. Johansson P., Ray A., Zhou Q., Huang W., Karlsson K., Nyberg F. Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci Res 1997 27 : 185 189.
78. Johansson P., Lindqvist A., Nyberg F., Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol Biochem Behav 2000 67 : 271 279.
79. Harlan R. E., Brown H. E., Lynch C. S., D'Souza D., Garcia M. M. Androgenic-anabolic steroids blunt morphine-induced c-fos expression in the rat striatum: possible role of beta-endorphin. Brain Res 2000 853 : 99 104.
80. Celerier E., Yazdi M. T., Castane A., Ghozland S., Nyberg F., Maldonado R. Effects of nandrolone on acute morphine responses, tolerance and dependence in mice. Eur J Pharmacol 2003 465 : 69 81.
81. Knoll A. T., Meloni E. G., Thomas J. B., Carroll F. I., Carlezon W. A. Jr. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 2007 323 : 838 845.
82. Newton S. S., Thome J., Wallace T. L., Shirayama Y., Schlesinger L., Sakai N. et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 2002 22 : 10883 10890.
83. Agren G., Thiblin I., Tirassa P., Lundeberg T., Stenfors C. Behavioural anxiolytic effects of low-dose anabolic androgenic steroid treatment in rats. Physiol Behav 1999 66 : 503 509.
84. Triemstra J. L., Sato S. M., Wood R. I. Testosterone and nucleus accumbens dopamine in the male Syrian hamster. Psychoneuroendocrinology 2008 33 : 386 394.
85. Negus S. S., Pope H. G. Jr., Kanayama G., Wines J. D. Jr., Fischer B. D. Lack of evidence for opioid tolerance or dependence in Rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology 2001 26 : 789 796.
86. Daly R. C., Su T. P., Schmidt P. J., Pickar D., Murphy D. L., Rubinow D. R. Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 2001 58 : 172 177.
87. Lindqvist A. S., Johansson-Steensland P., Nyberg F., Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behav Brain Res 2002 133 : 21 9.
88. Ricci L. A., Rasakham K., Grimes J. M., Melloni R. H. Jr. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol Biochem Behav 2006 85 : 1 11.
89. Tamaki T., Shiraishi T., Takeda H., Matsumiya T., Roy R. R., Edgerton V. R. Nandrolone decanoate enhances hypothalamic biogenic amines in rats. Med Sci Sports Exerc 2003 35 : 32 8.
90. Kurling S., Kankaanpaa A., Ellermaa S., Karila T., Seppala T. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats. Brain Res 2005 1044 : 67 75.
91. Schwartzer J. J., Ricci L. A., Melloni R. H. Jr. Adolescent anabolic-androgenic steroid exposure alters lateral anterior hypothalamic serotonin-2A receptors in aggressive male hamsters. Behav Brain Res 2009 199 : 257 262.
92. Thiblin I., Finn A., Ross S. B., Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br J Pharmacol 1999 126 : 1301 1306.
93. Frye C. A. Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol. Pharmacol Biochem Behav 2007 86 : 354 367.
94. Kindlundh A. M., Lindblom J., Bergstrom L., Nyberg F. The anabolic-androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain. Neuroscience 2003 119 : 113 120.
95. Kindlundh A. M., Rahman S., Lindblom J., Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci Lett 2004 356 : 131 134.
96. Schroeder J. P., Packard M. G. Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats. Neurosci Lett 2000 282 : 17 20.
97. Birgner C., Kindlundh-Hogberg A. M., Alsio J., Lindblom J., Schioth H. B., Bergstrom L. The anabolic androgenic steroid nandrolone decanoate affects mRNA expression of dopaminergic but not serotonergic receptors. Brain Res 2008 1240 : 221 228.
98. Kindlundh A. M., Bergstrom M., Monazzam A., Hallberg M., Blomqvist G., Langstrom B. et al. Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography. Prog Neuropsychopharmacol Biol Psychiatry 2002 26 : 1303 1308.
99. Ricci L. A., Schwartzer J. J., Melloni R. H. Jr. Alterations in the anterior hypothalamic dopamine system in aggressive adolescent AAS-treated hamsters. Horm Behav 2009 55 : 348 355.
100. Schwartzer J. J., Ricci L. A., Melloni R. H. Jr. Interactions between the dopaminergic and GABAergic neural systems in the lateral anterior hypothalamus of aggressive AAS-treated hamsters. Behav Brain Res 2009.
101. Wood R. I. Reinforcing aspects of androgens. Physiol Behav 2004 83 : 279 289.
102. Henderson L. P. Steroid modulation of GABAA receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 2007 52 : 1439 1453.
103. Henderson L. P., Penatti C. A., Jones B. L., Yang P., Clark A. S. Anabolic androgenic steroids and forebrain GABAergic transmission. Neuroscience 2006 138 : 793 799.
104. Kurling S., Kankaanpaa A., Seppala T. Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats. Behav Brain Res 2008 189 : 191 201.
105. Célérier E., Ahdepil T., Wikander H., Berrendero F., Nyberg F., Maldonado R. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence. Neuropharmacology 2006 50 : 788 806.
106. Hochberg Z., Pacak K., Chrousos G. P. Endocrine withdrawal syndromes. Endocr Rev 2003 24 : 523 538.
107. Bahrke M. S., Yesalis C. E., Kopstein A. N., Stephens J. A. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med 2000 29 : 397 405.
108. Kindlundh A. M., Hagekull B., Isacson D. G., Nyberg F. Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health 2001 11 : 322 328.
109. Kindlundh A. M., Isacson D. G., Berglund L., Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 1999 94 : 543 553.
110. Nilsson S., Spak F., Marklund B., Baigi A., Allebeck P. Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst Use Misuse 2004 39 : 1183 1197.
111. Yesalis C. E., Bahrke M. S. Anabolic-androgenic steroids and related substances. Curr Sports Med Rep 2002 1 : 246 252.
112. Fingerhood M. I., Sullivan J. T., Testa M., Jasinski D. R. Abuse liability of testosterone. J Psychopharmacol 1997 11 : 59 63.
113. Pope H. G., Brower K. J. Treatment of anabolic-androgenic steroid-related disorders. In : Galanter M., Kleber H., editors. The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th edn. Washington, DC : American Psychiatric Publishing 2008, p. 237 246.
114. Pope H. G., Kanayama G., Ionescu-Pioggia M., Hudson J. I. Anabolic steroid users' attitudes towards physicians. Addiction 2004 99 : 1189 1194.
115. Dawson R. Drugs in sport - the role of the physician. J Endocrinol 2001 170 : 55 61.
116. Kutscher E. C., Lund B. C., Perry P. J. Anabolic steroids: a review for the clinician. Sports Med 2002 32 : 285 296.
117. World Health Organization. The International Classification of Diseases and Health-Related Problems (ICD-10), 2nd edn. Geneva : World Health Organization 2005.
118. Kanayama G., Brower K. J., Wood R. I., Hudson J. I., Pope H. G. Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry 2009 166 : 642 644.
119. Hughes J. Should criteria for drug dependence differ across drugs? In : Saunders J., Schuckit M., Sirovatka P., Regier D., editors. Diagnostic Issues in Substance Use Disorders: Refining the Research Agenda for DSM-V. Arlington, VA : American Psychiatric Association, 2007, p. 237 250.
120. United States Drug Enforcement Administration. United States Code Title 21; Controlled Substances Act; Section 812: Schedules of Controlled Substances. 2008. Available at: http://www.usdoj.gov/dea/pubs/csa/812.htm (accessed 8 August 2009).
121. United States Drug Enforcement Administration. DEA announces largest steroid enforcement action in U.S. history. 2007. Available at: http://www.usdoj.gov/dea/pubs/pressrel/pr092407.html (accessed 8 August 2009).
122. Choi P. Y., Pope H. G. Jr., Olivardia R. Muscle dysmorphia: a new syndrome in weightlifters. Br J Sports Med 2002 36 : 375 376 discussion 377.
123. Kanayama G., Barry S., Hudson J. I., Pope H. G. Jr. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry 2006 163 : 697 703.
124. Olivardia R., Pope H. G. Jr., Hudson J. I. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry 2000 157 : 1291 1296.
125. Pope C. G., Pope H. G., Menard W., Fay C., Olivardia R., Phillips K. A. Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image 2005 2 : 395 400.
126. Cole J. C., Smith R., Halford J. C., Wagstaff G. F. A preliminary investigation into the relationship between anabolic-androgenic steroid use and the symptoms of reverse anorexia in both current and ex-users. Psychopharmacology (Berl) 2003 166 : 424 429.
127. Schwerin M. J., Corcoran K. J., Fisher L., Patterson D., Askew W., Olrich T. et al. Social physique anxiety, body esteem, and social anxiety in bodybuilders and self-reported anabolic steroid users. Addict Behav 1996 21 : 1 8.
128. Chung B. Muscle dysmorphia in weightlifters. Br J Sports Med 2003 37 : 280 281.
129. Cafri G., Thompson J. K., Ricciardelli L., McCabe M., Smolak L., Yesalis C. Pursuit of the muscular ideal: physical and psychological consequences and putative risk factors. Clin Psychol Rev 2005 25 : 215 239.
130. Boyadjiev N. P., Georgieva K. N., Massaldjieva R. I., Gueorguiev S. I. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. J Sports Med Phys Fitness 2000 40 : 271 274.
131. Brower K. J. Withdrawal from anabolic steroids. Curr Ther Endocrinol Metab 1997 6 : 338 343.
132. Malone D. A. Jr., Dimeff R. J. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. J Clin Psychiatry 1992 53 : 130 132.
133. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol 2006 17 : 651 667.
134. Bickel W. K., Marsch L. A. Towards a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 2001 96 : 73 86.
135. Verdejo-Garcia A., Lawrence A. J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008 32 : 777 810.
136. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 2008.
137. Perry J. L., Carroll M. E. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 2008 200 : 1 26.
138. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 2005 8 : 1458 1463.
139. Rogers R. D., Robbins T. W. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001 11 : 250 257.
140. Dom G., Sabbe B., Hulstijn W., van den Brink W. Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies. Br J Psychiatry 2005 187 : 209 220.
141. van Honk J., Hermans E. J., Putman P., Montagne B., Schutter D. J. Defective somatic markers in sub-clinical psychopathy. Neuroreport 2002 13 : 1025 1027.
142. Mazas C. A., Finn P. R., Steinmetz J. E. Decision-making biases, antisocial personality, and early-onset alcoholism. Alcohol Clin Exp Res 2000 24 : 1036 1040.
143. Vassileva J., Gonzalez R., Bechara A., Martin E. M. Are all drug addicts impulsive? Effects of antisociality and extent of multidrug use on cognitive and motor impulsivity. Addict Behav 2007 32 : 3071 3076.
144. Petry N. M. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacology (Berl) 2002 162 : 425 432.
145. Kim Y. T., Lee S. J., Kim S. H. Effects of the history of conduct disorder on the Iowa Gambling Tasks. Alcohol Clin Exp Res 2006 30 : 466 472.
146. Ernst M., Grant S. J., London E. D., Contoreggi C. S., Kimes A. S., Spurgeon L. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry 2003 160 : 33 40.
147. Blair R. J., Colledge E., Mitchell D. G. Somatic markers and response reversal: is there orbitofrontal cortex dysfunction in boys with psychopathic tendencies? J Abnorm Child Psychol 2001 29 : 499 511.
148. Cooper C. J., Noakes T. D., Dunne T., Lambert M. I., Rochford K. A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br J Sports Med 1996 30 : 246 250.
149. Klotz F., Garle M., Granath F., Thiblin I. Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Arch Gen Psychiatry 2006 63 : 1274 1279.
150. Klotz F., Petersson A., Isacson D., Thiblin I. Violent crime and substance abuse: a medico-legal comparison between deceased users of anabolic androgenic steroids and abusers of illicit drugs. Forensic Sci Int 2007.
151. Perry P. J., Kutscher E. C., Lund B. C., Yates W. R., Holman T. L., Demers L. Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. J Forensic Sci 2003 48 : 646 651.
152. Porcerelli J. H., Sandler B. A. Narcissism and empathy in steroid users. Am J Psychiatry 1995 152 : 1672 1674.
153. Thiblin I., Kristiansson M., Rajs J. Anabolic androgenic steroids and behavioural patterns among violent offenders. J Forensic Psychiatry 1997 8 : 299 310.
154. Thiblin I., Parlklo T. Anabolic androgenic steroids and violence. Acta Psychiatr Scand Suppl 2002 412 : 125 128.
155. Yates W. R., Perry P. J., Andersen K. H. Illicit anabolic steroid use: a controlled personality study. Acta Psychiatr Scand 1990 81 : 548 550.
156. Gottesman I. I., Gould T. D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003 160 : 636 645.
157. Bing O., Heilig M., Kakoulidis P., Sundblad C., Wiklund L., Eriksson E. High doses of testosterone increase anticonflict behaviour in rat. Eur Neuropsychopharmacol 1998 8 : 321 323.
158. Boissy A., Bouissou M. F. Effects of androgen treatment on behavioral and physiological responses of heifers to fear-eliciting situations. Horm Behav 1994 28 : 66 83.
159. Hermans E. J., Putman P., Baas J. M., Gecks N. M., Kenemans J. L., van Honk J. Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology 2007 32 : 1052 1061.
160. van Honk J., Schutter D. J., Hermans E. J., Putman P., Tuiten A., Koppeschaar H. Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women. Psychoneuroendocrinology 2004 29 : 937 943.